P. Simmonds

发表

Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.

R. Huddart, D. Rea, L. Billingham, 2005, The New England journal of medicine.

PACE BOM chemotherapy: a 12-week regimen for advanced Hodgkin's disease.

G. Mead, J. Sweetenham, P. Simmonds, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

The JACS prospective cohort study of newly diagnosed women with breast cancer investigating joint and muscle pain, aches, and stiffness: pain and quality of life after primary surgery and before adjuvant treatment

J. Addington-hall, P. Simmonds, D. Fenlon, 2014, BMC Cancer.

Follow-up after curative treatment for colorectal cancer: longitudinal evaluation of patient initiated follow-up in the first 12 months

A. Richardson, L. Batehup, H. Gage, 2017, Supportive Care in Cancer.

The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer.

P. Simmonds, L. Nolan, A. Darby, 2011, Breast.

Managing patients with lung cancer

P. Simmonds, 1999, BMJ.

Palliative chemotherapy for advanced or metastatic colorectal cancer. Colorectal Meta-analysis Collaboration.

C. Davis, I. Fentiman, J. Northover, 2000, The Cochrane database of systematic reviews.

PROSPECTIVE STUDY OF OUTCOMES IN SPORADIC VERSUS HEREDITARY BREAST CANCER

D. Altman, D. Eccles, S. Ennis, 2004 .

Nurse-led models of chemotherapy care: mixed economy or nurse-doctor substitution?

S. Hawker, D. Fitzsimmons, S. George, 2005, Journal of advanced nursing.

Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center.

D. Wright, G. Mead, J. Gale, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel.

C. Sotiriou, C. Desmedt, D. Larsimont, 2004, Molecular cancer therapeutics.

Familial breast cancer: an investigation into the outcome of treatment for early stage disease

D. Eccles, G. Evans, S. Hodgson, 2004, Familial Cancer.

Management of Hereditary Breast Cancer

D. Eccles, G. Evans, N. Haites, 2002, Disease markers.

Quality of life and experience of care in women with metastatic breast cancer: a cross-sectional survey.

J. Haviland, E. Reed, P. Simmonds, 2012, Journal of pain and symptom management.

Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients

R. Eeles, S. Lakhani, D. Altman, 2020, British Journal of Cancer.

Lymphadenopathy due to amyloid deposition in non-Hodgkin's lymphoma.

D. Wright, G. Mead, P. Simmonds, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

A survey of joint and muscle aches, pain, and stiffness comparing women with and without breast cancer.

J. Addington-hall, P. Simmonds, D. Fenlon, 2013, Journal of pain and symptom management.

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study

David Evans, R. Eeles, D. Easton, 2018, The Lancet. Oncology.

UK guidance document: treatment of metastatic breast cancer.

D. Miles, I. Smith, I. Kunkler, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Management of spinal cord and cauda equina compression secondary to epidural metastatic disease in adults with malignant germ cell tumours.

G. Mead, J. Gale, P. Simmonds, 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

Orchidectomy after chemotherapy for patients with metastatic testicular germ cell cancer

P. Simmonds, T. Geldart, G. Mead, 2002, BJU international.

Orchiectomy after chemotherapy in patients with metastatic testicular cancer. Is it indicated?

G. Mead, P. Simmonds, C. Smart, 1995, Cancer.

Primary pure teratoma of the testis.

G. Mead, A. Lee, P. Simmonds, 1996, The Journal of urology.

Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.

D. Altman, D. Eccles, E. Copson, 2013, Journal of the National Cancer Institute.

Sex cord stromal testicular tumors: a clinical series--uniformly stage I disease.

J. Featherstone, G. Mead, P. Simmonds, 2009, The Journal of urology.

Abstract S2-03: Does BRCA status affect outcome in young breast cancer patients? Results from the prospective study of outcomes in sporadic and hereditary breast cancer (POSH)

D. Easton, D. Altman, A. Dunning, 2017 .

A complicated case of metastatic teratoma

G. Mead, P. Simmonds, J. Whitehouse, 1995 .

A complicated case of metastatic teratoma. Growing teratoma syndrome and cerebral metastasis.

G. Mead, P. Simmonds, J. Whitehouse, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Enteropathy-Type I ntestinal T -Cell L ymphoma: C linical Features a nd T reatment o f 3 1 P atients i n a S ingle C enter

D. Wright, G. Mead, J. Gale, 2000 .

Late relapse (>2 years) on surveillance in stage I non‐seminomatous germ cell tumours; predominant seminoma only histology

P. Simmonds, L. Nolan, J. Kirby, 2010, BJU international.

Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers

P. Møller, Å. Borg, N. Loman, 2007, Hereditary cancer in clinical practice.

Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer.

J. Hardy, J. Mansi, G. van Tienhoven, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer

D. Eccles, W. Tapper, S. Ennis, 2008, Breast Cancer Research.

Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial.

K. Hood, P. Barrett-Lee, A. Casbard, 2014, The Lancet. Oncology.

Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.

K. Friedrichs, S. Chan, T. Pintér, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel

D. Larsimont, M. Piccart, K. Friedrichs, 2004, Breast Cancer Research and Treatment.

Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern Ireland

Robin L. Jones, P. Dileo, S. Strauss, 2020, Clinical Sarcoma Research.

Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.

H. Earl, D. Rea, S. M. Crawford, 2006, The New England journal of medicine.

Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.

R. Cathomas, G. Mead, M. Fehr, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients

R. Eeles, S. Lakhani, D. Altman, 2020, British Journal of Cancer.

Unmet supportive care needs of breast, colorectal and testicular cancer survivors in the first 8 months post primary treatment: A prospective longitudinal survey

A. Richardson, L. Batehup, H. Gage, 2021, European journal of cancer care.

The clinical features and management of testicular germ cell tumours in patients aged 60 years and older

G. Mead, P. Simmonds, L. Nolan, 2011, BJU international.

Randomized trial of marker-directed versus standard schedule zoledronic acid for bone metastases from breast cancer.

L. Hayward, R. Coleman, P. Simmonds, 2012 .

Thymic hyperplasia in adults following chemotherapy for malignancy.

P. Simmonds, M. Silberstein, J. McKendrick, 1993, Australian and New Zealand journal of medicine.

Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?

L. Fallowfield, A. Makris, D. Cameron, 2011, British Journal of Cancer.

Genitourinary tumors, non-prostate

S. J. Park, I. Tannock, S. Groshen, 2012 .

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

C. Caldas, E. Provenzano, J. Abraham, 2019, The Lancet.

Achievement Motivation : It May All Be About Self , After All

M. Maehr, P. Simmonds, 2004 .

Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age?

B. Daniele, D. Cunningham, P. Ross, 1999, European journal of cancer.

Living into old age with the consequences of breast cancer.

P. Coleman, R. Stephens, S. Payne, 2013, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials

C. Caldas, E. Provenzano, H. Earl, 2012, British Journal of Cancer.

Explorer Adjuvant epirubicin followed by cyclophosphamide , methotrexate and fluorouracil ( CMF ) vs CMF in early breast cancer : results with over 7 years median follow-up from the randomised phase III NEAT / BR 9601 trials

C. Caldas, E. Provenzano, P. Pharoah, 2018 .

Current Controversies in CancerShould chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age?: Contra:

P. Simmonds, L. Best, 1999 .

P. Simmonds, M. Wheater, 2011 .

Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis

P. Simmonds, P. Simmonds, 2000, BMJ : British Medical Journal.

Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies

O. Garden, G. Poston, J. Primrose, 2006, British Journal of Cancer.

Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol

D. Altman, D. Eccles, S. Ennis, 2007, BMC Cancer.

Improving patient experience of cancer follow up: redesign and evaluation of adult cancer aftercare services for breast, colorectal, and testicular patients, at University Hospital Southampton NHS Foundation Trust

A. Richardson, L. Batehup, H. Gage, 2014 .

Treating Breast Cancer

J. Cuzick, J. Forbes, X. Bonfill, 2003 .

Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.

S. Chan, T. Pintér, I. Bodrogi, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies

O. Garden, G. Poston, J. Primrose, 2006, British Journal of Cancer.

A phase 2 open-label study of carboplatin in combination with gemcitabine as a dose-dense schedule in patients with locally advanced or metastatic breast cancer that are resistant to anthracyclines and taxanes

T. Hickish, P. Barrett-Lee, A. Davies, 2020 .